New Studies Reveal Menopause Often Begins Earlier Than Most Women Expect
Recent research indicates that over half of women aged 30-35 already experience moderate to severe perimenopause symptoms, yet most wait decades before seeking treatment.
New Antiviral Drug Ensitrelvir Shows Promise in Preventing COVID-19 After Household Exposure
The SCORPIO-PEP international trial found that ensitrelvir reduced COVID-19 infection risk by 67% in household contacts when administered within 72 hours of exposure.
Managing the Complex Balance: MPN Treatment Challenges with JAK Inhibitors
Myelofibrosis patients face significant symptom burden that requires treatment intervention, with JAK inhibitors being the primary therapeutic option currently available.
Bevacizumab Addition to First-Line Chemotherapy Shows Real-World Benefit in High-Risk Ovarian Cancer
Real-world data confirms adding bevacizumab to first-line chemotherapy significantly extends time to next treatment in high-risk epithelial ovarian cancer patients from 11.7 to 13.6 months.
© Copyright 2025. All Rights Reserved by MedPath